Literature DB >> 17557193

NTPDase and 5'-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis.

Claudio A M Leal1, Maria R C Schetinger, Daniela B R Leal, Karine Bauchspiess, Clarissa M L Schrekker, Paula A Maldonado, Vera M Morsch, José E P da Silva.   

Abstract

The nucleotide degrading enzymes, ectonucleotidases, present on the platelet surface of human pregnant with a normal (without complications) or high risk for thrombosis (hypertension and gestational diabetes) were studied. NTPDase (E.C. 3.6.1.5, CD39) and 5'-nucleotidase (E.C. 3.1.3.5, CD73) activities of four patient groups, non-pregnant (NP, n = 18), pregnant without complications (P, n = 25), pregnant with hypertension (HP, n = 15) and pregnant with gestational diabetes mellitus (GDP, n = 10), were analyzed. Increased NTPDase activities were observed in the groups P (37.0%, S.D. = 2.03 and 34.0%, S.D. = 3.19), HP (40.0%, S.D. = 3.32 and 56.0%, S.D. = 3.25) and GDP (23.0%, S.D. = 2.30 and 42.0%, S.D. = 2.26) in comparison to the control group NP (p < 0.01, S.D. = 1.92 and S.D. = 2.48) when ATP and ADP were used as substrate, respectively. AMP was used as substrate to determine the 5'-nucleotidase activities, which showed to be elevated in the groups P (45.0%, S.D. = 1.73), HP (54.0%, S.D. = 2.64) and GDP (68.0%, S.D. = 1.69) when compared to the control group NP (p < 0.01, S.D. = 1.26). However, no statistically significant differences were observed between the groups P, HP and GDP. As a consequence, the enhanced ATP, ADP and AMP hydrolysis was ascribed to the pregnancy itself, independent of a normal or high risk for thrombosis. The enhanced NTPDase and 5'-nucleotidase activities in platelets suggest that these enzymes are involved in the thromboregulation process in the pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17557193     DOI: 10.1007/s11010-007-9515-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

Review 1.  The role of platelets in diabetes-related vascular complications.

Authors:  A B Sobol; C Watala
Journal:  Diabetes Res Clin Pract       Date:  2000-09       Impact factor: 5.602

Review 2.  Blood coagulation.

Authors:  Lucy A Norris
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2003-06       Impact factor: 5.237

3.  Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies.

Authors:  Gilberto Inácio Lunkes; Daniela Lunkes; Francieli Stefanello; André Morsch; Vera Maria Morsch; Cinthia Melazzo Mazzanti; Maria Rosa Chitolina Schetinger
Journal:  Thromb Res       Date:  2003-02-15       Impact factor: 3.944

Review 4.  Venous thromboembolism during pregnancy.

Authors:  M R Toglia; J G Weg
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

5.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

6.  Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.

Authors:  Daniela B R Leal; Cristiane A Streher; Tiago N Neu; Fábio P Bittencourt; Cláudio A M Leal; José E P da Silva; Vera M Morsch; Maria R C Schetinger
Journal:  Biochim Biophys Acta       Date:  2004-10-06

Review 7.  Diabetes mellitus: a hypercoagulable state.

Authors:  M E Carr
Journal:  J Diabetes Complications       Date:  2001 Jan-Feb       Impact factor: 2.852

8.  Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.

Authors:  J Bellart; R Gilabert; J Fontcuberta; E Carreras; R M Miralles; L Cabero
Journal:  Am J Perinatol       Date:  1998-02       Impact factor: 1.862

9.  Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.

Authors:  A J Marcus; M J Broekman; J H Drosopoulos; D J Pinsky; N Islam; C R Maliszewsk
Journal:  Ital Heart J       Date:  2001-11

Review 10.  Co-activation of platelets by prolactin or leptin--pathophysiological findings and clinical implications.

Authors:  H Wallaschofski; A Kobsar; O Sokolova; M Eigenthaler; T Lohmann
Journal:  Horm Metab Res       Date:  2004-01       Impact factor: 2.936

View more
  2 in total

1.  Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease.

Authors:  Viviane do Carmo Gonçalves Souza; Karine B Schlemmer; Cristiano B Noal; Jeandre A S Jaques; Margarete D Bagatini; Victor C Pimentel; Luiz Felipe D Carli; Cláudio A M Leal; Juliana Fleck; Maria B Moretto; Maria R C Schetinger; Daniela B R Leal
Journal:  Purinergic Signal       Date:  2012-07-01       Impact factor: 3.765

Review 2.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.